BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Hepa Wash Closes 7 Million Euros Financing Round


7/6/2011 12:57:10 PM

Munich, July 4th, 2011 - The medical device company Hepa Wash GmbH, located in Munich, successfully completed a financing round acquiring a seven million euros investment in the company. "I am especially very pleased that this is an internal round of financing. The private investors and the KfW-Bank nearly doubled their investment in Hepa Wash”, says CEO Dr. Bernhard Kreymann.

The invested amount is well above the current investment trend. The average amount per investment (without public investors) in the first quarter of this year was about 0.8 million euros, assessed by the Munich-based venture capital and private equity advisory "Fleischhauer, Hoyer & Partner" in a sample of 36 leading investment companies established in Germany.

CEO Dr. Bernhard Kreymann expressed satisfaction on the conclusion of this round of financing: "The progress of the clinical study is ensured, and the CE certification of the dialysis device as well as the construction of the production plant for dialysis fluids can move forward quickly."

About the Hepa Wash GmbH

The Hepa Wash GmbH, which is located in the "Munich Technology Center" (MTZ), started in 2005 as a one-man company. Business purpose is the development and marketing of a new liver support device, to reduce the high mortality rate of patients with liver failure. Recent studies have shown once again that so far existing therapies have only very little positive impact on the survival of liver patients. However, the Hepa Wash® device has a significantly increased detoxification capacity. The data of the in vitro and preclinical studies confirm the excellent effects of the patented procedure. The clinical pilot study at the Klinikum rechts der Isar in Munich was started in October 2010. Its first results corroborate the data of the in-vitro and preclinical studies. In parallel with the pilot study Hepa Wash will complete the CE certification of the device and start its own fluid production.

More Information:

Description of the Hepa Wash-Device.

Contact

Catherine Schreiber, Hepa Wash GmbH

Agnes-Pockels-Bogen 1 • 80992 München • Germany

Phone: +49 (89) 4111842-31 • Fax: +49 (89) 4111842-09

Email: Catherine.Schreiber@hepawash.com • Web: www.hepawash.com


Read at BioSpace.com


Hepa Wash
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->